Specific Molecular Targets to Control Tropical Diseases

Author(s): Juan B. Rodriguez.

Journal Name: Current Pharmaceutical Design

Volume 7 , Issue 12 , 2001

Become EABM
Become Reviewer

Abstract:

Chagas disease or American trypanosomiasis is considered by the Word Health Organization to be one of the important tropical parasitic diseases worldwide together with malaria and schistosomiasis. The etiologic agent of this illness is the kinetoplastid protozoon Trypanosoma cruzi. The present chemotherapy for the treatment of Chagas disease remains unsolved. The drugs currently in use are old, ineffective and toxic. Bearing in mind the metabolic differences between the parasite and the mammalian host, some attractive interesting molecular targets for drug design are presented.

Keywords: Molecular Targets, Tropical Diseases, Chagas disease, Malaria, schistosomiasis, Trypanosoma cruzi, Inhibitors, 4-PhenoxyphenoxyethylAllyl Ether, Tetrahydro-2H-pyran- 2-yl Ether, Potent Sulfur-containing Derivatives

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 7
ISSUE: 12
Year: 2001
Page: [1105 - 1116]
Pages: 12
DOI: 10.2174/1381612013397555
Price: $58

Article Metrics

PDF: 6